Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.625EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.581EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.590EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.496EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.49 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDCEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JR.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.6.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used